Skip to content
healthcare.dev

equate lansoprazole

NDC 49035-373, lansoprazole, tablet, orally disintegrating, delayed release, from Wal-Mart Stores Inc.

Product NDC
49035-373
Status
Listed
Labeler
Wal-Mart Stores Inc
Dosage form
TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
NDA
Application
NDA208025
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/49035-373 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LANSOPRAZOLE15 mg/1

Pharmacologic classes

Inhibition Gastric Acid Secretion [PE]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

Package NDCNDC-11Package
49035-373-554903503735542 BLISTER PACK in 1 CARTON (49035-373-55) / 1 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 49035-373 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/49035-373 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 49035-373. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.